CVI Holdings LLC Makes New $711,000 Investment in Surrozen, Inc. (NASDAQ:SRZN)

CVI Holdings LLC bought a new position in shares of Surrozen, Inc. (NASDAQ:SRZNFree Report) in the second quarter, Holdings Channel reports. The firm bought 64,905 shares of the company’s stock, valued at approximately $711,000. Surrozen accounts for 0.6% of CVI Holdings LLC’s portfolio, making the stock its 23rd largest position.

Separately, Armistice Capital LLC bought a new stake in Surrozen during the second quarter worth approximately $2,080,000. 66.57% of the stock is owned by hedge funds and other institutional investors.

Surrozen Stock Down 0.8 %

Shares of Surrozen stock opened at $10.25 on Friday. The stock has a 50 day moving average price of $8.51 and a two-hundred day moving average price of $10.02. Surrozen, Inc. has a 12-month low of $4.50 and a 12-month high of $16.19.

Surrozen (NASDAQ:SRZNGet Free Report) last announced its earnings results on Monday, August 12th. The company reported ($1.54) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.79) by $1.25. On average, analysts predict that Surrozen, Inc. will post -9.49 EPS for the current fiscal year.

Surrozen Company Profile

(Free Report)

Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.

See Also

Want to see what other hedge funds are holding SRZN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surrozen, Inc. (NASDAQ:SRZNFree Report).

Institutional Ownership by Quarter for Surrozen (NASDAQ:SRZN)

Receive News & Ratings for Surrozen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surrozen and related companies with MarketBeat.com's FREE daily email newsletter.